Investigational Site Number 1061 — Wellesley, Massachusetts

Investigational Site Number 1061 is a clinical research site located in Wellesley, Massachusetts, United States 02481.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 1061 has participated in 1 clinical trials.

Therapeutic areas: Relapsing Remitting Multiple Sclerosis.

Sponsors: Genzyme, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wellesley

Browse all research sites in Massachusetts · View every site in Wellesley

• Spaulding Rehabilitation Hospital, Wellesley Outpatient Center
• Dragonfly Research
• Research Site
• Novartis Investigative Site
• Harvard Pilgrim Health Care
• Vascular Care Group
• The Elliot Lewis Center for Multiple Sclerosis Care
• Pediatric Physicians' Organization at Children's
• Dermatology Partners
• Dermatology PartnersInc. /ID# 234946
• Wellesley Vision Group at Optical Design
• Aesthetic + Mind MD

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 1061?

Investigational Site Number 1061 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 1061 conducted?

Investigational Site Number 1061 has 1 clinical trials on record. Their work covers Relapsing Remitting Multiple Sclerosis.

Is Investigational Site Number 1061 accredited by Crixeo Clinical Trials?

Investigational Site Number 1061 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 1061?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.